Zassi Medical Evolutions Inc.
This article was originally published in Start Up
Executive Summary
Hoping to eliminate the stigma and inconvenience of ostomies, Zassi Medical Evolutions Inc. has developed a bag-free system for managing the waste that is redirected through a stoma in the abdominal wall. Zassi's Continent Ostomy Port system is designed to free patients from external collection devices taped to their stomachs. The company has signed a licensing and distribution deal with ostomy market leader Bristol-Myers Squibb's ConvaTec division.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.